PubRank

Marianna Fontana

Author PubWeight™ 23.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 2013 4.21
2 Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013 3.53
3 Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging 2013 1.99
4 Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. N Engl J Med 2015 1.84
5 Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007 1.66
6 Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 2012 1.25
7 Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014 0.97
8 Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure. Clin Chem 2007 0.91
9 Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. Clin Chem 2007 0.89
10 Clinical relevance of non-cardiac determinants of natriuretic peptide levels. Clin Chem Lab Med 2008 0.84
11 The search for a pathophysiological link between gender, cardiac endocrine function, body mass regulation and cardiac mortality: proposal for a working hypothesis. Clin Chim Acta 2009 0.83
12 Selective right ventricular impairment following coronary artery bypass graft surgery. Eur J Cardiothorac Surg 2009 0.81
13 CMR-verified interstitial myocardial fibrosis as a marker of subclinical cardiac involvement in LMNA mutation carriers. JACC Cardiovasc Imaging 2013 0.80
14 Prognostic value of plasma renin activity in heart failure. Am J Cardiol 2011 0.80
15 The empowerment of translational research: lessons from laminopathies. Orphanet J Rare Dis 2012 0.80
16 Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J Card Fail 2008 0.78
17 T1 mapping: non-invasive evaluation of myocardial tissue composition by cardiovascular magnetic resonance. Expert Rev Cardiovasc Ther 2014 0.75
18 Reply: Myocardial extracellular volume measurement by cardiac magnetic resonance. JACC Cardiovasc Imaging 2014 0.75
19 Cardiovascular magnetic resonance in the evaluation of heart failure: a luxury or a need? J Cardiovasc Med (Hagerstown) 2012 0.75
20 Heart muscle disease and cardiovascular magnetic resonance imaging. Br J Hosp Med (Lond) 2014 0.75
21 CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy. JACC Cardiovasc Imaging 2017 0.75
22 [Cardiomyopathy and hypereosinophilia: a post-partum case]. Recenti Prog Med 2009 0.75
23 Natriuretic peptide testing in primary care patients. Clin Chem Lab Med 2008 0.75
24 Should Histologic Determination of Amyloid Load Determine Management Decisions in Light-Chain Amyloidosis? J Am Coll Cardiol 2016 0.75
25 Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure. Adv Clin Chem 2009 0.75
26 [Differential diagnosis of dyspnea: the incremental value of lung ultrasound]. Recenti Prog Med 2010 0.75